NANOG and cancer: Michela Lupia et al. recorded that the recognized cancer-initiating cell markers, CD44, NANOG, POU5F1 and SOX2, were at higher levels in OC cells, which may drive tumor onset and recurrence, thus contributing to the high death/incidence ratio of OC [22].